registrieren | anmelden | FAQ      [?] 

Tag outcomes [127 articles]

Recent papers classified by the tag outcomes.
  • Analysis of factors contributing to success or failure of 1-stage urethroplasty for urethral stricture disease.
    J Urol, Vol. 151, No. 4. (April 1994), pp. 869-874.
    posted to outcomes surgery urethroplasty by zkyken on 2007-08-19 01:47:04 as **
  • Coordinate regulation of enzyme markers for inflammation and for protection against oxidants and electrophiles.
    Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, No. 41. (14 October 2008), pp. 15926-15931.
  • Impact of gene expression profiling tests on breast cancer outcomes.
    Evidence report/technology assessment, No. 160. (December 2007), pp. 1-105.
  • Cytokines and their relationship to the symptoms and outcome of cancer
    Nature Reviews Cancer, Vol. 8, No. 11. (10 October 2008), pp. 887-899.
    by Bostjan Seruga, Haibo Zhang, Lori J Bernstein, Ian F Tannock
  • Commercialized multigene predictors of clinical outcome for breast cancer.
    The oncologist, Vol. 13, No. 5. (May 2008), pp. 477-493.
    by JS Ross, C Hatzis, WF Symmans, L Pusztai, GN Hortobágyi
  • Formulary issues at a pediatric hospital: experience at Children's National Medical Center.
    Hosp Formul, Vol. 26, No. 6. (June 1991), pp. 500-510.
    by GJ Cohen, SJ Allen
    posted to bm formulary oncology outcomes by worx11 on 2007-09-20 20:14:23 as ** along with 1 group XROWXR
  • Cost considerations in the management of cancer in the older patient.
    Oncology (Williston Park), Vol. 21, No. 7. (June 2007)
    by JM McKoy, KA Fitzner, BJ Edwards, M Alkhatib, CC Tigue, NJ Nonzee, CR Bolden, CL Bennett
    posted to bm oncology outcomes by worx11 on 2007-09-20 18:54:02 as ** along with 1 group XROWXR
  • Cost effectiveness of extended adjuvant letrozole in postmenopausal women after adjuvant tamoxifen therapy: the UK perspective.
    Pharmacoeconomics, Vol. 24, No. 3. (2006), pp. 237-250.
    by J Karnon, T Delea, SR Johnston, R Smith, J Brandman, J Sung, PE Goss
    posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 19:16:06 as ** along with 1 group XROWXR
  • Cost effectiveness of imatinib compared with interferon-alpha or hydroxycarbamide for first-line treatment of chronic myeloid leukaemia.
    Pharmacoeconomics, Vol. 23, No. 5. (2005), pp. 515-526.
    by K Dalziel, A Round, R Garside, K Stein
    posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 19:27:07 as ** along with 1 group XROWXR
  • Cost effectiveness of imatinib mesylate in the treatment of advanced gastrointestinal stromal tumours.
    Clin Drug Investig, Vol. 27, No. 2. (2007), pp. 85-93.
  • Many new cancer drugs in the United Kingdom are facing negative NICE rulings.
    J Clin Oncol, Vol. 25, No. 18. (20 June 2007)
    by E Low,
    posted to bm oncology outcomes by worx11 on 2007-09-20 20:11:50 as ** along with 1 group XROWXR
  • Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service.
    Clin Ther, Vol. 26, No. 9. (September 2004), pp. 1546-1561.
  • European perspective on the costs and cost-effectiveness of cancer therapies.
    J Clin Oncol, Vol. 25, No. 2. (10 January 2007), pp. 191-195.
    by MF Drummond, AR Mason
    posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 20:08:00 as ** along with 1 group XROWXR
  • Cost-effectiveness of oral ibandronate compared with intravenous (i.v.) zoledronic acid or i.v. generic pamidronate in breast cancer patients with metastatic bone disease undergoing i.v. chemotherapy.
    Support Care Cancer, Vol. 13, No. 12. (December 2005), pp. 975-986.
    by E De Cock, J Hutton, P Canney, JJ Body, P Barrett-Lee, MP Neary, G Lewis
    posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 20:21:31 as ** along with 1 group XROWXR
  • Cost-utility analysis of imatinib mesilate for the treatment of advanced stage chronic myeloid leukaemia.
    Br J Cancer, Vol. 89, No. 4. (18 August 2003), pp. 634-640.
    by A Gordois, P Scuffham, E Warren, S Ward
    posted to bm cost-utility oncology outcomes by worx11 on 2007-09-20 19:30:11 as ** along with 1 group XROWXR
  • Cost-effectiveness of letrozole versus tamoxifen as initial adjuvant therapy in hormone receptor-positive postmenopausal women with early-stage breast cancer.
    Clin Breast Cancer, Vol. 7, No. 8. (June 2007), pp. 608-618.
    by TE Delea, J Karnon, O Sofrygin, SK Thomas, NL Papo, V Barghout
    posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 19:18:02 as ** along with 1 group XROWXR
  • Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis.
    Health Technol Assess, Vol. 8, No. 28. (July 2004)
    by K Dalziel, A Round, K Stein, R Garside, A Price
    posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 19:27:43 as ** along with 1 group XROWXR
  • Cost-effectiveness of oral ibandronate versus IV zoledronic acid or IV pamidronate for bone metastases in patients receiving oral hormonal therapy for breast cancer in the United Kingdom.
    Clin Ther, Vol. 27, No. 8. (August 2005), pp. 1295-1310.
    by E De Cock, J Hutton, P Canney, JJ Body, P Barrett-Lee, MP Neary, G Lewis
    posted to bm cost-effectiveness oncology outcomes by worx11 on 2007-09-20 20:23:29 as ** along with 1 group XROWXR
  • Cost-utility analysis of imatinib mesylate for the treatment of chronic myelogenous leukemia in the chronic phase.
    Clin Ther, Vol. 26, No. 11. (November 2004), pp. 1924-1933.
    by E Warren, S Ward, A Gordois, P Scuffham
    posted to bm cost-utility oncology outcomes by worx11 on 2007-09-20 19:25:17 as ** along with 1 group XROWXR
  • Outcomes of a Medicare Part D education program.
    J Am Pharm Assoc (Wash DC), Vol. 47, No. 3. (n 2007), pp. 382-384.
    by LM Howell, WE Wade, M Perri
  • Cost-utility of adjuvant hormone therapies with aromatase inhibitors in post-menopausal women with breast cancer: upfront anastrozole, sequential tamoxifen-exemestane and extended tamoxifen-letrozole.
    Breast, Vol. 16, No. 3. (June 2007), pp. 252-261.
    by C Skedgel, D Rayson, R Dewar, T Younis
    posted to bm cost-utility oncology outcomes by worx11 on 2007-09-20 19:02:57 as ** along with 1 group XROWXR
  • Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia.
    Clin Infect Dis, Vol. 36, No. 11. (1 June 2003), pp. 1418-1423.
    by TP Lodise, PS McKinnon, L Swiderski, MJ Rybak
    posted to delay outcomes by wilvc on 2007-06-13 12:47:44 as ** along with 1 person and 1 group blink UWNICU
  • One-year survival and neurological outcome after pediatric cardiopulmonary resuscitation.
    Intensive Care Med, Vol. 28, No. 3. (March 2002), pp. 365-368.
    posted to cpr outcomes by wilvc on 2006-01-22 23:49:37 as ** along with 1 group UWNICU
  • Low superior vena cava flow and neurodevelopment at 3 years in very preterm infants.
    J Pediatr, Vol. 145, No. 5. (November 2004), pp. 588-592.
    by RW Hunt, N Evans, I Rieger, M Kluckow
    posted to nicu outcomes by wilvc on 2007-11-29 15:55:42 as **
  • Low superior vena cava flow and intraventricular haemorrhage in preterm infants.
    Arch Dis Child Fetal Neonatal Ed, Vol. 82, No. 3. (May 2000)
    by M Kluckow, N Evans
    posted to icu nicu outcomes by wilvc on 2007-11-29 15:55:11 as **
  • Academic-Clinician Partnerships A Model for Outcomes Research
    Occupational Therapy in Health Care, Vol. 19 (30 August 2005), pp. 95-106.
    by Karen A Stern
  • Measuring the outcomes of assistive technology: challenge and innovation.
    Assist Technol, Vol. 8, No. 2. (1996), pp. 71-81.
    by RO Smith
  • Effect of cognitive rehabilitation on outcomes for persons with traumatic brain injury: A systematic review.
    J Head Trauma Rehabil, Vol. 14, No. 3. (June 1999), pp. 277-307.
    by N Carney, RM Chesnut, H Maynard, NC Mann, P Patterson, M Helfand
  • Therapy outcome measures for allied health practitioners in Australia: the AusTOMs
    Int J Qual Health Care, Vol. 16, No. 4. (1 August 2004), pp. 285-291.
    by Alison Perry, Meg Morris, Carolyn Unsworth, Stephen Duckett, Jemma Skeat, Karen Dodd, Nicholas Taylor, Karen Reilly
  • Reliability, validity, and applicability of the Quebec User Evaluation of Satisfaction with assistive Technology (QUEST 2.0) for adults with multiple sclerosis.
    Disability and rehabilitation, Vol. 24, No. 1-3. (5 2002), pp. 21-30.
  • The Psychosocial Impact of Assistive Devices Scale PIADS: Translation and preliminary psychometric evaluation of a Canadian-French version
    pp. 583-592.
    by L Demers
  • Conceptualization and measurement of assistive technology usability
    Disability and Rehabilitation: Assistive Technology, Vol. 2, No. 4. (2007), pp. 235-248.
    by Sajay Arthanat, Stephen M Bauer, James A Lenker, Susan M Nochajski, Yow W Wu
  • Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome.
    Health technology assessment (Winchester, England), Vol. 8, No. 9. (March 2004)
  • Psychometric and administrative properties of measures used in assistive technology device outcomes research.
    Assist Technol, Vol. 17, No. 1. (2005), pp. 7-22.
    by JA Lenker, MJ Scherer, MJ Fuhrer, JW Jutai, F DeRuyter
  • Speech recognition software as an assistive device: a pilot study of user satisfaction and psychosocial impact.
    Work (Reading, Mass.), Vol. 25, No. 2. (2005), pp. 125-134.
    by R Derosier, RS Farber
  • Key dimensions of client satisfaction with assistive technology: a cross-validation of a Canadian measure in The Netherlands.
    Journal of rehabilitation medicine : official journal of the UEMS European Board of Physical and Rehabilitation Medicine, Vol. 33, No. 4. (July 2001), pp. 187-191.
  • Feasibility of a classification system for physical therapy, occupational therapy, and sports therapy interventions for mobility and self-care in spinal cord injury rehabilitation.
    Archives of physical medicine and rehabilitation, Vol. 89, No. 8. (August 2008), pp. 1454-1459.
    posted to sci outcomes outcome-measure by willwade on 2008-10-24 15:06:17 as **
  • Development of a clinical measure of postural control for assessment of adaptive seating in children with neuromotor disabilities.
    Phys Ther, Vol. 71, No. 12. (December 1991), pp. 981-993.
    by SE Fife, LA Roxborough, RW Armstrong, SR Harris, JL Gregson, D Field
  • Validity of the AusTOM scales: A comparison of the AusTOMs and EuroQol-5D
    Health and Quality of Life Outcomes, Vol. 2, No. 1. (2004)
    by Carolyn Unsworth, Stephen Duckett, Dianne Duncombe, Alison Perry, Jemma Skeat, Nicholas Taylor
    posted to assessment outcome-measure outcomes qol tom validity by willwade on 2008-03-20 15:06:35 as **
  • Therapists' and Clients' Perceptions of the Occupational Performance History Interview
    Occupational Therapy in Health Care, Vol. 19 (30 August 2005), pp. 173-192.
    by Ashwini Apte, Gary Kielhofner, Amy Paul-Ward, Brent Braverman
  • A structured review of outcome measures used for the assessment of rehabilitation interventions for spinal cord injury
    Spinal Cord, Vol. aop, No. current.
    by J Dawson, D Shamley, MA Jamous
    posted to sci outcomes outcome-measure by willwade on 2008-10-24 18:07:32 as **
  • Toward a comprehensive evaluation of the impact of electronic aids to daily living: evaluation of consumer satisfaction.
    Disability and rehabilitation, Vol. 24, No. 1-3. (5 2002), pp. 115-125.
    by SM Shone, S Ryan, PJ Rigby, JW Jutai
  • Predicting satisfaction with assistive technology for a sample of adults with new spinal cord injuries.
    Psychological reports, Vol. 87, No. 3 Pt 1. (December 2000), pp. 981-987.
    by MJ Scherer, LA Cushman
  • A new conceptual model for assistive technology outcomes research and practice.
    Assist Technol, Vol. 16, No. 1. (2004), pp. 1-10.
    by JA Lenker, VL Paquet
  • Development of a scale to measure the psychosocial impact of assistive devices: lessons learned and the road ahead.
    Disabil Rehabil, Vol. 24, No. 1-3. (5 2002), pp. 31-37.
    by H Day, J Jutai, KA Campbell
  • Understanding the effects of printed health education materials: which features lead to which outcomes?
    J Health Commun, Vol. 6, No. 3. (p 2001), pp. 265-279.
    by FC Bull, CL Holt, MW Kreuter, EM Clark, D Scharff
  • Trabeculectomy With Mitomycin C in Pseudophakic Patients With Open-angle Glaucoma: Outcomes and Risk Factors For Failure
    American Journal of Ophthalmology, Vol. 141, No. 4. (April 2006), pp. 652-659.
    by Hector Fontana, Kouros Nouri-Mahdavi, Joseph Caprioli
    posted to factors glaucoma mitomycin outcomes risk trabeculectomy by univ0509 on 2006-10-07 17:11:17 as ***
  • Personality predictors of academic outcomes: Big Five correlates of GPA and SAT scores
    Journal of Personality and Social Psychology, Vol. 93, No. 1. (2007), pp. 116-130.
    by EE Noftle, RW Robins
    posted to academia eventualities outcomes by suizan on 2008-01-29 18:21:58 as **
  • Effectiveness of electronic aids to daily living: Increased independence and decreased frustration
    Australian Occupational Therapy Journal (March 2001), pp. 35-44.
    by Ruth Croser, Rob Garrett, Barry Seeger, Paul Davies
    posted to at outcomes by simonjudge on 2008-06-26 11:50:05 as ** along with 1 group AssistiveTechnology
  • Young Adult Outcome of Autism Spectrum Disorders
    Journal of Autism and Developmental Disorders
    by Linda Eaves, Helena Ho
    posted to autism outcomes by rvb on 2007-09-24 21:31:18 as **
  • Bemerkung: Sie können diese Seite wie folgt zitieren: http://www.citeulike.org/tag/outcomes

    Result page: 1 2 3 Next RIS BibTeX
    CiteULike organises scholarly (or academic) papers or literature and provides bibliographic (which means it makes bibliographies) for universities and higher education establishments. It helps undergraduates and postgraduates. People studying for PhDs or in postdoctoral (postdoc) positions. The service is similar in scope to EndNote or RefWorks or any other reference manager like BibTeX, but it is a social bookmarking service for scientists and humanities researchers.